
Krishna Kumar Ramlochan Dubey
About Krishna Kumar Ramlochan Dubey
Data last updated:
Krishna Kumar Ramlochan Dubey has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Wellfino Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Wellfino Pharmaceutical Private Limited at ₹1.50 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 Jul 2021 | 2021 | ₹1.50 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Krishna Kumar Ramlochan Dubey
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Krishna Kumar Ramlochan Dubey
Krishna Kumar Ramlochan Dubey has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Wellfino Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Wellfino Pharmaceutical Private Limited at ₹1.50 Cr (FY 2025).
Krishna Kumar Ramlochan Dubey is associated with 1 company as Director, including Wellfino Pharmaceutical Private Limited (₹1.50 Cr).
Krishna Kumar Ramlochan Dubey has expertise in General Business.
Krishna Kumar Ramlochan Dubey has 5 years in corporate governance.
By reported revenue, the largest current company of Krishna Kumar Ramlochan Dubey is Wellfino Pharmaceutical Private Limited, with revenue of ₹1.50 Cr (FY 2025).
Krishna Kumar Ramlochan Dubey currently holds positions at 1 company: Wellfino Pharmaceutical Private Limited (₹1.50 Cr).